| COVID-19 |
1 |
1 |
| Autopsy |
0 |
0.47 |
| New York |
0 |
0.47 |
| Atherosclerosis |
0 |
0.4 |
| Coronary Artery Disease (CAD) |
0 |
0.33 |
| Lipids Management |
0 |
0.27 |
| Artery |
0 |
0.24 |
| Blood |
0 |
0.24 |
| Cytokines |
0 |
0.24 |
| Fellowship |
0 |
0.24 |
| Hospital |
0 |
0.24 |
| Hyperlipidemia |
0 |
0.24 |
| Infarction |
0 |
0.24 |
| Interleukin |
0 |
0.24 |
| Cardiovascular Risk Management |
0 |
0.23 |
| Cardiometabolic Risk Factors |
0 |
0.12 |
| Myocardial Infarction (MI) |
0 |
0.12 |
| Biologic Therapy |
0 |
0.07 |
| Hypertension |
0 |
0.07 |
| Obesity |
0 |
0.07 |
| Type 2 Diabetes Mellitus |
0 |
0.07 |